Atrial fibrillation trials in Tunisia

1 trial · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 4Enrolling by invitation
  Apixaban Versus Rivaroxaban in Non Valvular Atrial Fibrillation

  Where

  Tunis

  Age

  18 years to 80 years

  People

  120

  Run by

  Les Laboratoires des Médicaments Stériles

  See details and how to joinNCT06862726